• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磁共振引导下的大分割放疗:局限性前列腺癌的当前新出现数据及前景展望

MR-Guided Hypofractionated Radiotherapy: Current Emerging Data and Promising Perspectives for Localized Prostate Cancer.

作者信息

Cuccia Francesco, Corradini Stefanie, Mazzola Rosario, Spiazzi Luigi, Rigo Michele, Bonù Marco Lorenzo, Ruggieri Ruggero, Buglione di Monale E Bastia Michela, Magrini Stefano Maria, Alongi Filippo

机构信息

Advanced Radiation Oncology Department, Sacro Cuore Don Calabria Hospital, 37024 Negrar di Valpolicella, Italy.

Department of Radiation Oncology, University Hospital Munich Campus Grosshadern, 81377 Munchen, Germany.

出版信息

Cancers (Basel). 2021 Apr 9;13(8):1791. doi: 10.3390/cancers13081791.

DOI:10.3390/cancers13081791
PMID:33918650
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8070332/
Abstract

In this review we summarize the currently available evidence about the role of hybrid machines for MR-guided radiotherapy for prostate stereotactic body radiotherapy. Given the novelty of this technology, to date few data are accessible, but they all report very promising results in terms of tolerability and preliminary clinical outcomes. Most of the studies highlight the favorable impact of on-board magnetic resonance imaging as a means to improve target and organs at risk identification with a consequent advantage in terms of dosimetric results, which is expected to relate to a more favorable toxicity pattern. Still, the longer treatment time per session may potentially affect the patient's compliance to the treatment, although first quality of life assessment studies have reported substantial tolerability and no major impact on quality of life. Finally, in this review we hypothesize some future scenarios of further investigation, based on the possibility to explore the superior anatomy visualization and the role of daily adapted treatments provided by hybrid MR-Linacs.

摘要

在本综述中,我们总结了关于混合机器在磁共振引导下的前列腺立体定向体部放射治疗中的作用的现有证据。鉴于这项技术的新颖性,目前可获取的数据很少,但所有数据均报告了在耐受性和初步临床结果方面非常有前景的结果。大多数研究强调了机载磁共振成像作为一种改善靶区和危及器官识别的手段所产生的有利影响,进而在剂量学结果方面具有优势,这有望带来更有利的毒性模式。尽管首批生活质量评估研究报告了较高的耐受性且对生活质量没有重大影响,但每次治疗时间较长仍可能会影响患者对治疗的依从性。最后,在本综述中,基于探索混合磁共振直线加速器提供的卓越解剖结构可视化以及每日适应性治疗的作用的可能性,我们推测了一些未来进一步研究的情景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/780a/8070332/e8a7ef327ced/cancers-13-01791-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/780a/8070332/e67eccedb483/cancers-13-01791-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/780a/8070332/063192d2972c/cancers-13-01791-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/780a/8070332/eebe47f72d23/cancers-13-01791-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/780a/8070332/e8a7ef327ced/cancers-13-01791-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/780a/8070332/e67eccedb483/cancers-13-01791-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/780a/8070332/063192d2972c/cancers-13-01791-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/780a/8070332/eebe47f72d23/cancers-13-01791-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/780a/8070332/e8a7ef327ced/cancers-13-01791-g004.jpg

相似文献

1
MR-Guided Hypofractionated Radiotherapy: Current Emerging Data and Promising Perspectives for Localized Prostate Cancer.磁共振引导下的大分割放疗:局限性前列腺癌的当前新出现数据及前景展望
Cancers (Basel). 2021 Apr 9;13(8):1791. doi: 10.3390/cancers13081791.
2
A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT).一项随机 II 期试验研究了 MR 引导下前列腺立体定向体部放疗,对于局限性前列腺癌(FORT)患者分别采用 5 或 2 个剂量分割进行治疗。
BMC Cancer. 2023 Sep 30;23(1):923. doi: 10.1186/s12885-023-11430-z.
3
1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment.1.5TMR 引导下的每日自适应 SBRT 治疗前列腺癌:可行性、初步临床耐受性、治疗期间的生活质量和患者报告的结果。
Radiat Oncol. 2020 Mar 23;15(1):69. doi: 10.1186/s13014-020-01510-w.
4
Rectal spacer hydrogel in 1.5T MR-guided and daily adapted SBRT for prostate cancer: dosimetric analysis and preliminary patient-reported outcomes.1.5T MR 引导下每日自适应 SBRT 中直肠间隔水凝胶在前列腺癌中的应用:剂量学分析和初步患者报告结果。
Br J Radiol. 2021 Jan 1;94(1117):20200848. doi: 10.1259/bjr.20200848. Epub 2020 Nov 2.
5
Functional imaging guided stereotactic ablative body radiotherapy (SABR) with focal dose escalation and bladder trigone sparing for intermediate and high-risk prostate cancer: study protocol for phase II safo trial.功能成像引导下的立体定向消融体部放射治疗(SABR),针对中高危前列腺癌进行局部剂量递增并保留膀胱三角区:II期SAFO试验的研究方案
Radiat Oncol. 2024 May 3;19(1):54. doi: 10.1186/s13014-024-02440-7.
6
Patient positioning and immobilization procedures for hybrid MR-Linac systems.混合 MR-Linac 系统的患者定位和固定程序。
Radiat Oncol. 2021 Sep 20;16(1):183. doi: 10.1186/s13014-021-01910-6.
7
MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.磁共振引导自适应与 ITV 基础立体定向体部放疗治疗肝转移瘤(MAESTRO):一项随机对照的 II 期临床试验。
Radiat Oncol. 2022 Mar 27;17(1):59. doi: 10.1186/s13014-022-02033-2.
8
Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy.水凝胶直肠周围间隔物插入对 1.5T MR 引导立体定向体部放疗中前列腺内部分运动的影响。
Radiat Oncol. 2020 Jul 22;15(1):178. doi: 10.1186/s13014-020-01622-3.
9
Dosimetric benefit of online treatment plan adaptation in stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer.在线治疗计划调整在立体定向超分割磁共振引导下的局部前列腺癌放疗中的剂量学益处。
Front Oncol. 2024 Feb 15;14:1308406. doi: 10.3389/fonc.2024.1308406. eCollection 2024.
10
Clinical Outcomes of Prostate SBRT Using Non-adaptive MR-Guided Radiotherapy.基于非自适应磁共振引导放疗的前列腺 SBRT 的临床结果。
Cancer Control. 2024 Jan-Dec;31:10732748241270595. doi: 10.1177/10732748241270595.

引用本文的文献

1
Artificial Intelligence (AI)-Driven Adaptive Motion Management in Helical and Robotic Radiotherapy: Innovations, Challenges, and Future Directions.人工智能驱动的螺旋式和机器人放射治疗中的自适应运动管理:创新、挑战与未来方向
Cureus. 2025 Apr 4;17(4):e81702. doi: 10.7759/cureus.81702. eCollection 2025 Apr.
2
Dose-volume parameter evaluation of a sub-fractionation workflow for adaptive radiotherapy of prostate cancer patients on a 1.5 T magnetic resonance imaging radiotherapy system.在1.5T磁共振成像放射治疗系统上对前列腺癌患者进行自适应放射治疗的子分割工作流程的剂量体积参数评估。
Phys Imaging Radiat Oncol. 2025 Jan 30;33:100706. doi: 10.1016/j.phro.2025.100706. eCollection 2025 Jan.
3

本文引用的文献

1
ESTRO-ACROP recommendations on the clinical implementation of hybrid MR-linac systems in radiation oncology.ESTRO-ACROP 关于放射肿瘤学中混合 MR-直线加速器系统临床实施的建议。
Radiother Oncol. 2021 Jun;159:146-154. doi: 10.1016/j.radonc.2021.03.025. Epub 2021 Mar 26.
2
Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: Results From the FLAME Randomized Phase III Trial.局部前列腺癌外照射放疗中前列腺内肿瘤焦点增强:来自 FLAME 随机 III 期试验的结果。
J Clin Oncol. 2021 Mar 1;39(7):787-796. doi: 10.1200/JCO.20.02873. Epub 2021 Jan 20.
3
In reply to Fiorino et al.: The central role of the radiation oncologist in the multidisciplinary & multiprofessional model of modern radiation therapy.
Feasibility and Acute Toxicity of Hypo-Fractionated Radiotherapy on 0.35T MR-LINAC: The First Prospective Study in Spain.
0.35T磁共振直线加速器低分割放疗的可行性与急性毒性:西班牙的首项前瞻性研究
Cancers (Basel). 2024 Apr 26;16(9):1685. doi: 10.3390/cancers16091685.
4
Stereotactic prostate radiotherapy with or without androgen deprivation therapy, study protocol for a phase III, multi-institutional randomized-controlled trial.立体定向前列腺放射治疗联合或不联合雄激素剥夺治疗,一项III期多机构随机对照试验的研究方案。
BJR Open. 2022 Nov 29;4(1):20220032. doi: 10.1259/bjro.20220032. eCollection 2022.
5
Optimal planning target margin for prostate radiotherapy based on interfractional and intrafractional variability assessment during 1.5T MRI-guided radiotherapy.基于1.5T MRI引导放疗期间分次间和分次内变异性评估的前列腺放疗最佳计划靶区边缘
Front Oncol. 2023 Dec 20;13:1337626. doi: 10.3389/fonc.2023.1337626. eCollection 2023.
6
Adoption of Hybrid MRI-Linac Systems for the Treatment of Brain Tumors: A Systematic Review of the Current Literature Regarding Clinical and Technical Features.混合动力 MRI-直线加速器系统在脑肿瘤治疗中的应用:当前文献中关于临床和技术特征的系统评价。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231199286. doi: 10.1177/15330338231199286.
7
Hypofractionation of radiation dose to the prostate does not necessarily imply a greater risk of acute radiation proctitis.对前列腺的放射剂量进行大分割照射并不一定意味着急性放射性直肠炎的风险更高。
Clin Transl Radiat Oncol. 2023 Sep 16;43:100679. doi: 10.1016/j.ctro.2023.100679. eCollection 2023 Nov.
8
Stereotactic Magnetic Resonance-Guided Adaptive and Non-Adaptive Radiotherapy on Combination MR-Linear Accelerators: Current Practice and Future Directions.基于磁共振线性加速器组合的立体定向磁共振引导自适应与非自适应放射治疗:当前实践与未来方向。
Cancers (Basel). 2023 Mar 30;15(7):2081. doi: 10.3390/cancers15072081.
9
MRI-LINAC: A transformative technology in radiation oncology.磁共振成像直线加速器:放射肿瘤学中的一项变革性技术。
Front Oncol. 2023 Jan 27;13:1117874. doi: 10.3389/fonc.2023.1117874. eCollection 2023.
10
1.5T MR-Guided Daily-Adaptive SBRT for Prostate Cancer: Preliminary Report of Toxicity and Quality of Life of the First 100 Patients.1.5T磁共振引导下前列腺癌每日适应性立体定向体部放疗:首批100例患者毒性反应及生活质量的初步报告
J Pers Med. 2022 Nov 30;12(12):1982. doi: 10.3390/jpm12121982.
回复菲奥里诺等人:放射肿瘤学家在现代放射治疗多学科和多专业模式中的核心作用。
Radiother Oncol. 2021 Feb;155:e20-e21. doi: 10.1016/j.radonc.2020.11.034. Epub 2020 Dec 30.
4
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.EAU-EANM-ESTRO-ESUR-SIOG 前列腺癌指南-2020 版更新。第 1 部分:筛查、诊断和以治愈为目的的局部治疗。
Eur Urol. 2021 Feb;79(2):243-262. doi: 10.1016/j.eururo.2020.09.042. Epub 2020 Nov 7.
5
Magnetic resonance image-guided adaptive stereotactic body radiotherapy for prostate cancer: preliminary results of outcome and toxicity.磁共振引导自适应立体定向体部放疗治疗前列腺癌:疗效和毒性的初步结果。
Br J Radiol. 2021 Jan 1;94(1117):20200696. doi: 10.1259/bjr.20200696. Epub 2020 Oct 29.
6
Rectal spacer hydrogel in 1.5T MR-guided and daily adapted SBRT for prostate cancer: dosimetric analysis and preliminary patient-reported outcomes.1.5T MR 引导下每日自适应 SBRT 中直肠间隔水凝胶在前列腺癌中的应用:剂量学分析和初步患者报告结果。
Br J Radiol. 2021 Jan 1;94(1117):20200848. doi: 10.1259/bjr.20200848. Epub 2020 Nov 2.
7
Adaptive SBRT by 1.5 T MR-linac for prostate cancer: On the accuracy of dose delivery in view of the prolonged session time.1.5TMR 直线加速器自适应 SBRT 治疗前列腺癌:考虑到治疗时间延长,评估剂量传递的准确性。
Phys Med. 2020 Dec;80:34-41. doi: 10.1016/j.ejmp.2020.09.026. Epub 2020 Oct 20.
8
Safety, Efficacy, and Patterns of Failure After Single-Fraction Stereotactic Body Radiation Therapy (SBRT) for Oligometastases.寡转移病灶单次分割立体定向体放射治疗(SBRT)后的安全性、疗效和失败模式。
Int J Radiat Oncol Biol Phys. 2021 Mar 1;109(3):756-763. doi: 10.1016/j.ijrobp.2020.10.011. Epub 2020 Oct 15.
9
Problems and Promises of Introducing the Magnetic Resonance Imaging Linear Accelerator Into Routine Care: The Case of Prostate Cancer.将磁共振成像直线加速器引入常规治疗的问题与前景:以前列腺癌为例
Front Oncol. 2020 Sep 2;10:1741. doi: 10.3389/fonc.2020.01741. eCollection 2020.
10
Daily dosimetric variation between image-guided volumetric modulated arc radiotherapy and MR-guided daily adaptive radiotherapy for prostate cancer stereotactic body radiotherapy.图像引导容积调强弧形治疗与磁共振引导每日自适应放疗治疗前列腺癌立体定向体部放疗的日常剂量学差异。
Acta Oncol. 2021 Feb;60(2):215-221. doi: 10.1080/0284186X.2020.1821090. Epub 2020 Sep 18.